![]() |
市场调查报告书
商品编码
1961421
CBD宠物市场-全球产业规模、份额、趋势、机会和预测:按动物类型、适应症、分销管道、地区和竞争格局划分,2021-2031年CBD Pet Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Animal Type, By Indication, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球 CBD 宠物市场预计将从 2025 年的 2.5648 亿美元大幅成长至 2031 年的 5.0652 亿美元,复合年增长率为 12.01%。
此市场领域涵盖了以大麻为原料的CBD产品(外用溶液、咀嚼片、油剂等),旨在缓解宠物的发炎、疼痛和焦虑。推动该行业发展的关键因素包括宠物日益人性化以及消费者从传统药物转向天然、整体健康疗法。这种转变得益于CBD产品良好的安全性。根据美国国家动物营养补充品委员会(NASC)2024年的数据,CBD产品的不利事件发生率仅为每百万剂2.1例,这进一步增强了消费者对这些疗法的信心。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 2.5648亿美元 |
| 市场规模:2031年 | 5.0652亿美元 |
| 复合年增长率:2026-2031年 | 12.01% |
| 成长最快的细分市场 | 狗 |
| 最大的市场 | 北美洲 |
儘管市场有所成长,但监管的不确定性仍是市场扩张的主要障碍。 CBD作为兽用饲料添加剂尚未获得联邦政府核准,且缺乏统一的法律框架,这造成了合规负担,并阻碍了兽医专业人员正式开立此类产品处方。这种缺乏标准化的情况使州际贸易复杂化,并限制了大型零售商全面采用此类产品的能力。因此,由于这些持续存在的监管复杂性,该行业在获得更广泛的商业性认可方面面临挑战。
宠物人性化和优质化的趋势日益加速,正成为全球CBD宠物市场的主要驱动力,从根本上改变了消费者的购买习惯。随着饲主越来越将宠物视为家庭成员,也越来越愿意投资符合人类健康趋势的高品质、健康型产品。根据福布斯顾问公司2025年10月的调查,51%的宠物主人认为他们的宠物是重要的家庭成员,与人类同等重要。这种强烈的情感纽带正在推动对高端护理产品的需求,并显着增强该行业的经济实力。美国宠物产品协会于2025年3月发布的《2025年产业趋势报告》数据显示,2024年美国宠物产业的总支出达到1,520亿美元,凸显了饲主与其宠物之间纽带所创造的巨大经济规模,这也为CBD品牌将其产品定位为健康必需品奠定了基础。
同时,宠物慢性病和老龄化相关疾病的增加直接推动了人们对自然疗法的接受度。饲主正在积极寻求传统药物以外的整体疗法来应对行为压力和运动功能障碍等问题,而这些正是大麻二酚(CBD)的主要用途。根据美国宠物用品协会于2024年8月发布的《2024年犬猫报告》,自2018年以来,犬类镇静剂的使用量激增了168%。这一增长表明消费者对缓解焦虑解决方案的偏好发生了明显转变,这直接有利于旨在减轻压力的CBD配方。随着对功能性疼痛和焦虑管理的需求不断增长,CBD注入的零食和精油市场也持续扩张,以满足这些治疗需求。
监管的不确定性是全球CBD宠物市场商业性扩张的主要障碍。 CBD尚未被联邦政府核准为饲料添加剂,这造成了巨大的法律责任风险,使得大型全国性零售商对销售此类产品犹豫不决。这种被排除在高流量销售管道之外的情况,限制了CBD产品在分散的线上和专卖市场的销售,导致消费者认知度和购买管道有限。此外,由于缺乏联邦监管,兽医专业人员无法推荐此类疗法,从而有效地切断了医疗建议与产品应用之间的关键联繫。
儘管消费者需求显而易见,但市场成熟仍面临诸多限制因素。美国宠物用品协会 (APPA) 2024 年的报告显示,CBD 产品拥有稳固的基本客群,12% 的狗饲主会为他们的宠物使用 CBD 产品。然而,持续存在的法律不确定性仍然是限制市场发展的瓶颈,阻碍了该行业利用这一需求实现大规模应用。如果没有一个标准化的法规结构来保障安全性和合法性,该产业就无法透过融入主流零售市场来充分释放其成长潜力。
乳化技术的应用正在改变产品功效,解决了传统脂质基大麻素生物利用度低的问题。製造商正积极采用这种先进的加工方法,将CBD油分解成细小颗粒,显着增加宠物消化道的吸收面积。这项创新使得水溶性配方成为可能,与传统酊剂相比,确保了更稳定的治疗效果和更快的起效速度。在2024年4月发表于《兽医学前沿》(Frontiers in Veterinary Science)的一项题为「四种大麻二酚製剂在犬单次口服给药后的药代动力学行为」的研究中,奈米乳化製剂在3小时内即可达到92至314 μg/L的血浆峰浓度,显示其吸收速度优于其他方式。
同时,市场正经历透过策略性收购进行的整合阶段,这表明成熟的动物保健公司和投资机构正在进入该领域。这一趋势凸显了市场正从分散的小规模企业向成熟的环境转变,资本投资推动了扩充性和分销。大型公司正在收购成功的营养补充品品牌,以实现产品组合多元化,并利用这些细分市场参与者建立的良好信誉。正如《宠物食品行业》杂誌在2024年12月报导的那样,“预计2025年宠物行业的併购活动将激增”,私募股权投资者在11月下旬收购宠物营养补充剂公司FoodScience,正是该行业金融发展的一个象征性例证,也表明机构投资者对高质量营养相关资产的兴趣日益浓厚。
The Global CBD Pet Market is projected to expand significantly, growing from USD 256.48 Million in 2025 to USD 506.52 Million by 2031, reflecting a compound annual growth rate of 12.01%. This market sector includes hemp-derived cannabidiol products, such as topicals, chews, and oils, developed to relieve inflammation, pain, and anxiety in companion animals. Key drivers propelling this industry include the increasing humanization of pets and a consumer shift toward natural, holistic health alternatives rather than traditional pharmaceuticals. This transition is supported by strong safety records; according to 2024 data from the National Animal Supplement Council, adverse events for CBD products occurred at a rate of only 2.1 per one million administrations, reinforcing consumer trust in these therapies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 256.48 Million |
| Market Size 2031 | USD 506.52 Million |
| CAGR 2026-2031 | 12.01% |
| Fastest Growing Segment | Dogs |
| Largest Market | North America |
Despite this growth, regulatory uncertainty remains a significant barrier to wider market development. The lack of federal approval for CBD as a veterinary feed additive and inconsistent legal frameworks create compliance burdens that prevent veterinary professionals from officially prescribing these products. This absence of standardization complicates interstate trade and limits the ability of major retailers to fully adopt the category. Consequently, the industry faces challenges in achieving broader commercial acceptance due to these ongoing regulatory complexities.
Market Driver
The escalating trend of pet humanization and premiumization acts as a primary driver for the Global CBD Pet Market, fundamentally reshaping consumer purchasing habits. As owners increasingly regard their pets as essential family members, there is a greater willingness to invest in high-quality, wellness-oriented products that align with human health trends. According to Forbes Advisor in October 2025, 51% of pet owners consider their animals to be as integral to the family as human members. This strong emotional connection fuels the demand for premium care options, contributing substantially to the industry's financial strength. Data from the American Pet Products Association's '2025 State of the Industry Report', released in March 2025, indicates that total U.S. pet industry spending reached $152 billion in 2024, highlighting the vast economic scale of the owner-pet bond that CBD brands are leveraging to position their products as wellness necessities.
Concurrently, the rising prevalence of chronic and age-related ailments in pets provides a direct pathway for the adoption of natural remedies. Owners are actively seeking holistic substitutes for conventional pharmaceuticals to manage issues like behavioral stress and mobility problems, which are primary use cases for cannabidiol. The American Pet Products Association reported in its '2024 Dog and Cat Report' from August 2024 that the usage of calming products for dogs has surged by 168% since 2018. This increase underscores a distinct consumer pivot toward anxiety-relief solutions, directly benefiting CBD formulations designed to mitigate stress. As the demand for functional pain and anxiety management grows, the market for CBD-infused treats and oils continues to expand to meet these therapeutic needs.
Market Challenge
Regulatory ambiguity acts as a major hurdle restricting the commercial scalability of the global CBD pet market. The lack of federal designation for CBD as an approved feed additive creates significant liability risks, discouraging major national retailers from stocking these products. This exclusion from high-traffic sales channels forces distribution into fragmented online and specialty markets, thereby limiting consumer visibility and accessibility. Furthermore, the absence of federal oversight prevents veterinary professionals from endorsing these therapies, effectively severing the critical connection between medical advice and product adoption.
This restriction on market maturation persists despite clear evidence of consumer demand. In 2024, the American Pet Products Association reported that 12% of dog owners utilized CBD products for their pets, demonstrating a viable customer base. However, continued legal uncertainty functions as a bottleneck, preventing the sector from capitalizing on this interest to achieve mass adoption. Without a standardized regulatory framework to assure safety and legality, the industry remains unable to unlock its full growth potential through integration into mainstream retail markets.
Market Trends
The adoption of nano-emulsion technology is transforming product efficacy by addressing the naturally low bioavailability associated with traditional lipid-based cannabinoids. Manufacturers are increasingly using this advanced processing method to break down CBD oil into microscopic particles, significantly increasing the surface area for absorption within a pet's digestive tract. This innovation enables water-soluble formulations that ensure more consistent therapeutic outcomes and faster onset times compared to conventional tinctures. A study published in Frontiers in Veterinary Science in April 2024, titled 'Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs', revealed that nano-emulsion based formulations achieved maximum plasma concentrations in the range of 92-314 μg/L within three hours, outperforming other delivery methods in rapid absorption.
Simultaneously, the market is undergoing a phase of consolidation through strategic acquisitions, signaling the entry of established animal health and equity firms into the space. This trend highlights a shift from fragmented, small-scale operations toward a matured landscape where capital investment drives scalability and distribution reach. Large entities are acquiring successful supplement brands to diversify portfolios and capitalize on the established trust these niche players have built. As noted by Petfood Industry in December 2024 regarding 'Pet industry M&As set to surge in 2025', the sector's financial evolution was exemplified by the acquisition of FoodScience pet supplements by private equity investors in late November, illustrating the heightened institutional interest in high-quality nutritional assets.
Report Scope
In this report, the Global CBD Pet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global CBD Pet Market.
Global CBD Pet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: